By expenditures
| Name | Title | Type |
|---|---|---|
| Ana M Ortiz | Principal Accountant | Auditee |
| Pablo Morales | Acting Controller | Auditee |
| Eliseo Luna | Audit Partner | Auditee |
| Samuel Carlo | Comptroller | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 372904 | 2024 | 2025-12-03 | LANDA UMPIERRE PSC | $69.05M |
| 327082 | 2023 | 2024-11-04 | Landa Umpierre Psc | $82.69M |
| 676 | 2022 | 2023-10-17 | Landa Umpierre Psc | $67.49M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 372904 | 2024 | 2025-12-03 | 1163380 | 2024-007 | Material Weakness | Yes | N |
| 372904 | 2024 | 2025-12-03 | 1163379 | 2024-006 | Material Weakness | Yes | N |
| 372904 | 2024 | 2025-12-03 | 1163378 | 2024-005 | Material Weakness | Yes | L |
| 372904 | 2024 | 2025-12-03 | 1163377 | 2024-004 | Material Weakness | Yes | AB |
| 372904 | 2024 | 2025-12-03 | 1163376 | 2024-003 | Material Weakness | Yes | AB |
| 372904 | 2024 | 2025-12-03 | 1163375 | 2024-002 | Material Weakness | Yes | L |
| 327082 | 2023 | 2024-11-04 | 1080963 | 2023-007 | Significant Deficiency | Yes | N |
| 327082 | 2023 | 2024-11-04 | 1080962 | 2023-006 | Material Weakness | Yes | L |
| 327082 | 2023 | 2024-11-04 | 1080961 | 2023-005 | Significant Deficiency | - | B |
| 327082 | 2023 | 2024-11-04 | 1080960 | 2023-004 | Significant Deficiency | Yes | AB |
| 327082 | 2023 | 2024-11-04 | 1080959 | 2023-003 | Significant Deficiency | Yes | AB |
| 327082 | 2023 | 2024-11-04 | 1080958 | 2023-002 | Material Weakness | Yes | L |
| 327082 | 2023 | 2024-11-04 | 504521 | 2023-007 | Significant Deficiency | Yes | N |
| 327082 | 2023 | 2024-11-04 | 504520 | 2023-006 | Material Weakness | Yes | L |
| 327082 | 2023 | 2024-11-04 | 504519 | 2023-005 | Significant Deficiency | - | B |
| 327082 | 2023 | 2024-11-04 | 504518 | 2023-004 | Significant Deficiency | Yes | AB |
| 327082 | 2023 | 2024-11-04 | 504517 | 2023-003 | Significant Deficiency | Yes | AB |
| 327082 | 2023 | 2024-11-04 | 504516 | 2023-002 | Material Weakness | Yes | L |
| 676 | 2022 | 2023-10-17 | 576779 | 2022-007 | Significant Deficiency | Yes | N |
| 676 | 2022 | 2023-10-17 | 576778 | 2022-006 | - | Yes | N |
| 676 | 2022 | 2023-10-17 | 576777 | 2022-005 | Material Weakness | Yes | L |
| 676 | 2022 | 2023-10-17 | 576776 | 2022-004 | Material Weakness | - | A |
| 676 | 2022 | 2023-10-17 | 576775 | 2022-003 | Material Weakness | - | N |
| 676 | 2022 | 2023-10-17 | 576774 | 2022-002 | Material Weakness | Yes | L |
| 676 | 2022 | 2023-10-17 | 337 | 2022-007 | Significant Deficiency | Yes | N |
| 676 | 2022 | 2023-10-17 | 336 | 2022-006 | - | Yes | N |
| 676 | 2022 | 2023-10-17 | 335 | 2022-005 | Material Weakness | Yes | L |
| 676 | 2022 | 2023-10-17 | 334 | 2022-004 | Material Weakness | - | A |
| 676 | 2022 | 2023-10-17 | 333 | 2022-003 | Material Weakness | - | N |
| 676 | 2022 | 2023-10-17 | 332 | 2022-002 | Material Weakness | Yes | L |